TriLink BioTechnologies, a Maravai LifeSciences company (MRVI), has partnered with, Avantor (AVTR) to expand availability of its innovative nucleic acid products to customers across Europe, Middle East, and Africa. This distribution partnership is expected to improve the ordering process and offer shorter lead times for European customers — increasing access to TriLink’s novel nucleic acid technologies
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTR:
Questions or Comments about the article? Write to editor@tipranks.com